1978/01/01 by Serdar Sander, R Nissen-Meyer, A. Aakvaag · 3 citations
Medicine · #Hormonal and reproductive studies #Prostate Cancer Treatment and Research #Sperm and Testicular Function
paper · doi:10.3109/00365597809179977
openalex publication_date 1978/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/06/26
Depostat treatment was found to reduce plasma testosterone and to have a gonadotrophin suppressive effect in males. In our study the clinical effect on prostatic cancer was, however, disappointing when compared to the well established effect of orchiectomy. The therapeutic failure of Depostat might be related to the incomplete suppression of plasma testosterone compared to that observed after orchiectomy.